GAIL (India) Limited (GAILF)
OTCMKTS · Delayed Price · Currency is USD
10.80
-2.00 (-15.63%)
At close: Feb 6, 2025
Sage Therapeutics Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 124,498 | 98,992 | 56,160 | 122,561 | 61,364 | Upgrade |
Depreciation & Amortization | - | 37,992 | 37,115 | 27,960 | 24,219 | 21,676 | Upgrade |
Loss (Gain) From Sale of Assets | - | 715.5 | 272.7 | 213.3 | 120.8 | 55.1 | Upgrade |
Asset Writedown & Restructuring Costs | - | -935.7 | 941.5 | -299.6 | -237.5 | -643.5 | Upgrade |
Loss (Gain) From Sale of Investments | - | -161.9 | -48.3 | -68.1 | -184.8 | -94.9 | Upgrade |
Loss (Gain) on Equity Investments | - | -15,032 | -16,821 | -15,081 | -17,623 | -17,146 | Upgrade |
Provision & Write-off of Bad Debts | - | -151.1 | -734.8 | 126.9 | 544.9 | -1,121 | Upgrade |
Other Operating Activities | - | 9,639 | -5,547 | -2,674 | 781 | 1,634 | Upgrade |
Change in Accounts Receivable | - | -4,523 | 14,260 | -23,444 | -59,920 | 19,421 | Upgrade |
Change in Inventory | - | -2,892 | -453.1 | -23,411 | -5,912 | 1,924 | Upgrade |
Change in Accounts Payable | - | 8,202 | -2,120 | 12,564 | 29,851 | 2,865 | Upgrade |
Operating Cash Flow | - | 157,350 | 125,857 | 32,047 | 94,199 | 89,934 | Upgrade |
Operating Cash Flow Growth | - | 25.02% | 292.73% | -65.98% | 4.74% | 7.76% | Upgrade |
Capital Expenditures | - | -79,297 | -125,012 | -88,306 | -69,713 | -56,972 | Upgrade |
Sale of Property, Plant & Equipment | - | 128.7 | 137.3 | 774.9 | 327.4 | 132.4 | Upgrade |
Cash Acquisitions | - | - | 27,647 | - | - | - | Upgrade |
Investment in Securities | - | 3,268 | 6,326 | 4,598 | 3,241 | -3,308 | Upgrade |
Other Investing Activities | - | 8,596 | 8,055 | 4,193 | 11,172 | 13,217 | Upgrade |
Investing Cash Flow | - | -67,378 | -82,734 | -76,401 | -54,360 | -46,930 | Upgrade |
Long-Term Debt Issued | - | 77,131 | 130,599 | 105,216 | 22,402 | 39,244 | Upgrade |
Total Debt Issued | - | 77,131 | 130,599 | 105,216 | 22,402 | 39,244 | Upgrade |
Long-Term Debt Repaid | - | -109,255 | -115,150 | -23,899 | -17,977 | -35,261 | Upgrade |
Total Debt Repaid | - | -109,255 | -115,150 | -23,899 | -17,977 | -35,261 | Upgrade |
Net Debt Issued (Repaid) | - | -32,124 | 15,449 | 81,317 | 4,425 | 3,984 | Upgrade |
Repurchase of Common Stock | - | - | - | -13,289 | - | -12,810 | Upgrade |
Common Dividends Paid | - | -42,754 | -36,205 | -30,693 | -39,954 | -22,381 | Upgrade |
Other Financing Activities | - | -14,530 | -13,818 | -7,615 | -3,638 | -3,499 | Upgrade |
Financing Cash Flow | - | -89,409 | -34,574 | 29,721 | -39,167 | -34,706 | Upgrade |
Foreign Exchange Rate Adjustments | - | 1,148 | 473.5 | 1,873 | -539.5 | 527.2 | Upgrade |
Net Cash Flow | - | 1,712 | 9,023 | -12,760 | 132.1 | 8,825 | Upgrade |
Free Cash Flow | - | 78,053 | 845.5 | -56,259 | 24,486 | 32,962 | Upgrade |
Free Cash Flow Growth | - | 9131.61% | - | - | -25.71% | - | Upgrade |
Free Cash Flow Margin | - | 5.50% | 0.06% | -3.86% | 2.64% | 5.75% | Upgrade |
Free Cash Flow Per Share | - | 11.87 | 0.13 | -8.53 | 3.68 | 4.87 | Upgrade |
Cash Interest Paid | - | 14,858 | 13,982 | 7,615 | 3,979 | 3,499 | Upgrade |
Cash Income Tax Paid | - | 24,903 | 32,741 | 16,138 | 32,842 | 13,020 | Upgrade |
Levered Free Cash Flow | - | 30,381 | -7,672 | -78,145 | 5,244 | 23,468 | Upgrade |
Unlevered Free Cash Flow | - | 35,056 | 1,072 | -73,086 | 6,489 | 24,517 | Upgrade |
Change in Net Working Capital | - | -3,658 | -20,093 | 43,959 | 28,620 | -26,893 | Upgrade |
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.